Mei‐Kwan Yau - Concepedia

Author

Mei‐Kwan Yau

The University of Queensland ORCID

Also Known As

M K Yau, M. Ya’u, M.K. Yau, Mei-Kwan (Annika) Yau, Mei-Kwan Yau, Mei‐Kwan Yau

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

The University of Queensland ARC Centre of Excellence in Advanced Molecular Imaging Australian Research Council Georgia Institute of Technology Mater Research

About

Mei‐Kwan Yau is an author at The University of Queensland specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	321
2	Natural Sciences	5	5	166
3	Biochemistry	5	5	166
4	Engineering	2	2	218
5	Biomedical Engineering	1	1	141

Mei‐Kwan Yau

Publications

962

Citations

H-Index

Page 1

	Year	Citations
Programmable multistage drug delivery to lymph nodes Alex Schudel, Asheley P. Chapman, Mei‐Kwan Yau, Nature Nanotechnology Cell-based Drug DeliveryNanomedicineEngineeringTargeted Drug DeliveryBiomedical Engineering	2020	141
Diet‐induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism Junxian Lim, Abishek Iyer, Ligong Liu, The FASEB Journal	2013	108
Toward Drugs for Protease-Activated Receptor 2 (PAR2) Mei‐Kwan Yau, Ligong Liu, David P. Fairlie Journal of Medicinal Chemistry InflammationCytokineAnti-inflammatoryPar2 StructureToward Drugs	2013	85
Mechanotransduction activates RhoA in the neighbors of apoptotic epithelial cells to engage apical extrusion Kinga Duszyc, Guillermo A. Gómez, Anne K. Lagendijk, Current Biology MechanobiologyEngineeringApical ExtrusionPhysiologyMorphogenesis	2021	77
Stereoelectronic Effects Dictate Molecular Conformation and Biological Function of Heterocyclic Amides Robert C. Reid, Mei‐Kwan Yau, Ranee Singh, Journal of the American Chemical Society Organic ChemistryHeterocycle ChemistryChemical BiologyHeterocyclic AmidesMedicinal Chemistry	2014	72
Pathway‐selective antagonism of proteinase activated receptor 2 Jacky Y. Suen, Adam J. Cotterell, Rink‐Jan Lohman, British Journal of Pharmacology	2014	69
A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells Yuhong Jiang, Mei‐Kwan Yau, Junxian Lim, Journal of Pharmacology and Experimental Therapeutics	2017	64
Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists Vernon Seow, Junxian Lim, Adam J. Cotterell, Scientific Reports	2016	45
Biased Signaling by Agonists of Protease Activated Receptor 2 Yuhong Jiang, Mei‐Kwan Yau, W. Mei Kok, ACS Chemical Biology	2017	43
Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a Rink‐Jan Lohman, Johan K. Hamidon, Robert C. Reid, Nature Communications	2017	43

Page 1